Summit Therapeutics Statistics
Total Valuation
SMMT has a market cap or net worth of $16.50 billion. The enterprise value is $15.81 billion.
Important Dates
The next estimated earnings date is Tuesday, May 12, 2026, after market close.
| Earnings Date | May 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SMMT has 776.08 million shares outstanding. The number of shares has increased by 4.06% in one year.
| Current Share Class | 776.08M |
| Shares Outstanding | 776.08M |
| Shares Change (YoY) | +4.06% |
| Shares Change (QoQ) | +3.09% |
| Owned by Insiders (%) | 78.52% |
| Owned by Institutions (%) | 15.27% |
| Float | 134.58M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 3,372.10 |
| PB Ratio | 25.02 |
| P/TBV Ratio | 25.12 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.87, with a Debt / Equity ratio of 0.03.
| Current Ratio | 9.87 |
| Quick Ratio | 9.77 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -206.10% and return on invested capital (ROIC) is -127.17%.
| Return on Equity (ROE) | -206.10% |
| Return on Assets (ROA) | -115.28% |
| Return on Invested Capital (ROIC) | -127.17% |
| Return on Capital Employed (ROCE) | -161.37% |
| Weighted Average Cost of Capital (WACC) | -3.26% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$4.07M |
| Employee Count | 265 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -9.40% in the last 52 weeks. The beta is -1.37, so SMMT's price volatility has been lower than the market average.
| Beta (5Y) | -1.37 |
| 52-Week Price Change | -9.40% |
| 50-Day Moving Average | 18.14 |
| 200-Day Moving Average | 19.81 |
| Relative Strength Index (RSI) | 52.68 |
| Average Volume (20 Days) | 3,880,048 |
Short Selling Information
The latest short interest is 34.50 million, so 25.60% of the outstanding shares have been sold short.
| Short Interest | 34.50M |
| Short Previous Month | 34.56M |
| Short % of Shares Out | 25.60% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 13.27 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -1.09B |
| Pretax Income | -1.08B |
| Net Income | -1.08B |
| EBITDA | -1.09B |
| EBIT | -1.09B |
| Earnings Per Share (EPS) | -$1.44 |
Full Income StatementBalance Sheet
The company has $713.45 million in cash and $20.89 million in debt, giving a net cash position of $692.56 million or $0.89 per share.
| Cash & Cash Equivalents | 713.45M |
| Total Debt | 20.89M |
| Net Cash | 692.56M |
| Net Cash Per Share | $0.89 |
| Equity (Book Value) | 658.86M |
| Book Value Per Share | 0.85 |
| Working Capital | 647.31M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$322.93 million and capital expenditures -$657,000, giving a free cash flow of -$323.59 million.
| Operating Cash Flow | -322.93M |
| Capital Expenditures | -657,000 |
| Depreciation & Amortization | 146,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -323.59M |
| FCF Per Share | -$0.42 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |